A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : TCGF / T cell growth factor

[Related PubMed/MEDLINE]
Total Number of Papers: 290
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   TCGF  (>> Co-occurring Abbreviation)
Long Form:   T cell growth factor
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2008 Biological properties of interleukin 2 and its role in pathogenesis of selected diseases--a review. IL-2
2008 IL-21 promotes survival and maintains a naive phenotype in human CD4+ T lymphocytes. ---
2008 Measurement of human and murine interleukin 2 and interleukin 4. IL-2, IL-4, MTT
2008 Preparing T cell growth factor from rat splenocytes. ---
2008 Technique for culturing Macaca mulatta peripheral blood lymphocytes for fluorescence in situ hybridization of whole chromosome paints. Con A, PHA, SEA
2006 [Discovery of immature thymocyte proliferation factor]. NPF
2004 The quantal theory of how the immune system discriminates between "self and non-self" IL-2, IL-2R, TCR
2003 Isolation of proliferation factor of immature T-cell clone in concanavalin A-stimulated splenocyte culture supernatant. mrH, NPF
2001 An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection. ---
10  2000 Blocking the common gamma-chain of cytokine receptors induces T cell apoptosis and long-term islet allograft survival. ---
11  1998 Characterization of phenotype related responsiveness of peripheral blood lymphocytes from Eimeria tenella infected chickens. MoAb
12  1997 Development of a highly quantitative, reproducible assay for determination of chicken T cell growth factor biological activity. DMEM, OD, RPMI
13  1996 T cell responses to Mycobacterium bovis in red deer, a large animal model for tuberculosis. BCG
14  1995 Absence of high-affinity binding sites for interferon alpha/beta in variant murine CD4+ T lymphocytes not expressing the T cell antigen receptor. IFN
15  1995 Direct cellular communications between CD45R0 and CD45RA T cell subsets via CD27/CD70. ---
16  1994 Impairment of T-cell growth-promoting lymphokines in human insulin-dependent diabetes mellitus. PBMC, PHA, SI
17  1994 Production of cytokines by lymphocytes from spleen, mesenteric lymph node and intestinal lamina propria of pigs. IL-2R, PCR
18  1994 Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL-1 and interferon-gamma. MC, PCR, PTEC
19  1994 Thy.1lowCD3- cells sorted from nylon wool-passed bone marrow cells can augment the H-2 identical but not non-identical cytotoxic T lymphocyte precursors in mixed lymphocyte cultures. CTL, LN, NW-BM, self-MHC, Th
20  1993 A multigene family on human chromosome 12 encodes natural killer-cell lectins. NK, RFLP
21  1993 Effect of physical exhaustion and glucocorticoids (dexamethasone) on T-cells of trained rats. BMC, C-dex, DEX
22  1993 Effects of chicken anemia virus on cell-mediated immune function in chickens exposed to the virus by a natural route. PI
23  1993 Enhanced chondrocyte destruction by lymphokine-activated killer cells. Possible role in rheumatoid arthritis. PMBC, RA, rIL-2
24  1993 Further characterization of an interleukin-2-like cytokine produced by Xenopus laevis T lymphocytes. IL-2, PHA
25  1993 The induction of murine tumor infiltrating lymphocytes (TIL) by interleukin-2 or T cell growth factor. Con A, rIL-2, TIL
26  1993 Transforming growth factor beta (TGF beta) is produced by and influences the proliferative response of Xenopus laevis lymphocytes. IL-2, TGF-beta
27  1992 A method for the analysis of biological transduction phenomena. Pb, PS/B
28  1992 Effect of synthetic thymic humoral factor (THF-gamma 2) on T cell activities in immunodeficient ageing mice. ---
29  1992 Immune system activation associated with a naturally occurring infection in Xenopus laevis. ---
30  1992 Use of T-cell growth factors (interleukins 2, 4, 7, 10, and 12) in the evaluation of T-cell reactivity to melanoma. IL-2, IL-4, LAK, TILs
31  1991 Cellular interactions regulating the in vitro response of bovine lymphocytes to ovalbumin. FACS, mAbs, OA, TCR
32  1991 Cervine T-lymphocyte growth factors and their measurement in tuberculosis. IL-2
33  1991 Effects of chicken anemia agent on lymphokine production and lymphocyte transformation in experimentally infected chickens. CAA, Con A, PI
34  1991 Lack of T cell oligoclonality in enzyme-digested synovial tissue and in synovial fluid in most patients with rheumatoid arthritis. MoAb, RA, TCR
35  1991 Patterns of cytokine production and proliferation by T lymphocytes differ in mice vaccinated or infected with Schistosoma mansoni. IFN-gamma, IL, LN, NI, Th
36  1991 Psychological status and immunological parameters of institutionalized aged. CDH, PHA
37  1991 Regulation of mitogen- and TCGF-induced lymphocyte blastogenesis by prostaglandins and supernatant from equine embryos and endometrium. Con A, PGs, PHA
38  1991 Role of glycosaminoglycans in the regulation of T cell proliferation induced by thymic stroma-derived T cell growth factor. TSTGF
39  1991 Suppression by sorted CD8+CD11b- cells from T-cell growth factor-activated peripheral blood lymphocytes on cytolytic activity against tumour in patients with gastric carcinoma. LAS, PBL
40  1990 Blastogenic responses and production of TCGF by mononuclear cells isolated from the bovine endometrium. MNCs
41  1990 Cellular basis of the proliferative response of human T cells to mouse xenoantigens. PBMC
42  1990 Functional and phenotypic characteristics of effusion-associated lymphoid cells cultured in the presence of either recombinant interleukin 2 or T-cell growth factor from malignant pleural and peritoneal effusions in patients with advanced carcinoma. EAL, rIL-2
43  1990 Functional and phenotypic characteristics of recombinant interleukin-2 or T-cell growth factor-activated splenic lymphoid cells from patients with gastric or hepatocellular carcinoma. LAK, NK, rIL-2
44  1990 Immunosuppressive properties of follicular fluid from preovulatory horse follicles. ---
45  1990 In vitro induction, expression and selection of thioguanine-resistant mutants with human T-lymphocytes. HPRT, PHA, TGr
46  1990 Interleukin-2 mRNA expression, lymphokine production and DNA synthesis in glutathione-depleted T cells. BSO, Con A, IL-2
47  1990 Isolation and characterization of NK cell or NK/T cell-specific cDNA clones. LCL, NK
48  1990 Production of bovine immunoregulatory molecules by xenogeneic hybrids. rhIL-2
49  1990 Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. GCs
50  1990 Trypanosoma cruzi: maintenance of parasite-specific T cell responses in lymph nodes during the acute phase of the infection. Con A, LN
51  1989 Determination of in vivo and in vitro radiosensitivity of mouse splenic T-lymphocytes using a T-cell cloning technique. CEs
52  1989 Differential activation of lymphokine-activated killer cells with different surface phenotypes by cultivation with recombinant interleukin 2 or T-cell growth factor in gastric cancer patients. LAK, NK, PBL, rIL-2
53  1989 Heterogeneous lymphokine-activated killer cell precursor populations. Development of a monoclonal antibody that separates two populations of precursors with distinct culture requirements and separate target-recognition repertoires. LAK, mAb, NK, rIL-2
54  1989 Lymphokine-activated suppressor (LAS) cells in patients with gastric carcinoma. LAK, LAS, PBL
55  1989 Production and consumption of T cell growth factor by peripheral blood lymphocytes of cattle infected with Taenia saginata. Con A, IL-2, p.i, PBL
56  1989 [Basic and clinical study of adoptive immunotherapy using cytotoxic T lymphocyte (CTL) against cancers]. CTL, CTL, PBL
57  1988 Highly lytic in vivo primed cytolytic T lymphocytes devoid of lytic granules and BLT-esterase activity acquire these constituents in the presence of T cell growth factors upon blast transformation in vitro. PEL
58  1988 Mechanisms of suppression in mixed allogeneic chimeras. NS, rIL-2, WBI
59  1988 Participation of suppressor-inducer cells in the suppression of adjuvant arthritis by transfer of spleen cells expanded by T cell growth factor. AA, Con A
60  1988 Production of human B and T cell growth factors is enhanced by thymic hormones. PBMC, T alpha 1, TF5
61  1988 Serum specifically potentiates the mitogenic response of Nb2 lymphoma cells to rat prolactin. ---
62  1988 Short-term lymphokine stimulation of human peripheral blood mononuclear cells generates cytolytic activity against endothelial cells: involvement of natural killer cells. AET-SRBC, EC, PBMC
63  1988 The ontogeny of interleukin production and responsivity in the frog, Xenopus. IL-1, LPS, PCs, PHA, SNs
64  1987 A factor with interleukin-1-like activity is produced by peritoneal cells from the frog, Xenopus laevis. IL-1, LPS, PCs, PHA, SNs
65  1987 Bovine helper T-cell clones specific for lymphocytes infected with Theileria parva (Muguga). MHC
66  1987 Characterization of mouse thymocyte subpopulations by the enzymatic marker 20-alpha-hydroxysteroid dehydrogenase: differential responses to IL-1 and IL-2. 20 alpha-SDH, Con A, IL-1, IL-2, PMA, rIL-1
67  1987 Growth of an interleukin 2/interleukin 4-dependent T cell line induced by granulocyte-macrophage colony-stimulating factor (GM-CSF). GM-CSF, RP-HPLC
68  1987 Human fetal lymphocytes require T cell growth factors for cytotoxic responses. MLC
69  1987 Human T cell clones reactive with hepatitis B virus (HBV) surface antigen from a HBV vaccine recipient. HBV
70  1987 Immunological studies in acquired immunodeficiency syndrome: effect of TCGF and indomethacine on the in vitro lymphocyte response. ARC, PBMC
71  1987 Methods for the selection and growth of antigen-specific cytolytic T lines and clones bearing a defined T cell receptor beta chain marker. CTL, TCR
72  1987 Mitogen-activated Xenopus laevis lymphocytes produce a T-cell growth factor. IL-2, PHA, SNs
73  1987 Production and assay of ovine T cell growth factor by concanavalin A stimulated peripheral blood leukocytes. Con A
74  1987 Quantitative assay of human T-cell leukemia/lymphoma virus transformation. HTLV-I
75  1987 Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans. HPRT, TG
76  1987 Regulation of T-cell activation and T-cell growth factor (TCGF) production by hydrogen peroxide. IL-2
77  1987 Regulation of T-cell functions by L-lactate. IL-1
78  1987 Simultaneous increased expression of E-rosette receptor (CD2, T11) and T cell growth factor receptor on human T lymphocytes during activation. PHA
79  1987 Transfer of spleen cells expanded by T cell growth factor suppresses arthritis induced in rats. AA, CIA, Con A
80  1986 Characterization of a murine lymphokine distinct from interleukin 2 and interleukin 3 (IL-3) possessing a T-cell growth factor activity and a mast-cell growth factor activity that synergizes with IL-3. IL-3, MCGF
81  1986 Chicken T-cell growth factor: use in the generation of a long-term cultured T-cell line and biochemical characterization. Con A
82  1986 Evaluation of lymphocytes' influence in luminol-dependent chemiluminescence emission of mouse spleen cells. CL, FA, KLH
83  1986 Immunological studies in the acquired immunodeficiency syndrome. II. Active suppression or intrinsic defect--investigated by mixing AIDS cells with HLA-DR identical normal cells. AIDS, Con A, MLC, PBMC, PHA, PPD, PWM
84  1986 Mechanisms of transplantation tolerance in B-cell-chimeric chickens. Impairment of tolerance by T cell growth factor. GVH, MLR, PBL
85  1986 Peripheral blood natural killer cell activity in human breast cancer patients and its modulation by T-cell growth factor and autologous plasma. NK
86  1986 Serial transmission of human T-cell leukemia virus type I by blood transfusion in rabbits and its prevention by use of X-irradiated stored blood. HTLV-I
87  1986 Suppression by alpha-fetoprotein of murine natural killer cell activity stimulated in vitro and in vivo by interferon and interleukin 2. AFP, NK
88  1986 T-cell involvement in benign phase chronic myelogenous leukemia. CML
89  1986 The glycoprotein nature and biosynthetic relationship of two molecularly distinct species of primate T-cell growth factor. ---
90  1986 The induction of the human T-cell growth factor receptor precedes the production of RNA and occurs in the presence of inhibitors of RNA synthesis. AO, PHA, PY
91  1986 [Interleukin-2 and cancer treatment]. CTL, IL-2, LAK
92  1985 Biological and biochemical characterization of bovine interleukin 2. Studies with cloned bovine T cells. Con A, IL-2
93  1985 Clinical response of a patient with diffuse histiocytic lymphoma to adoptive chemoimmunotherapy using cyclophosphamide and alloactivated haploidentical lymphocytes. A case report and phase I trial. CPM, MLC
94  1985 Cyclosporin A inhibits a discrete step in T-lymphocyte stimulation. CyA
95  1985 Detection of NK activity and antibody-dependent cellular cytotoxicity of lymphocytes by human tumor clonogenic assay--its correlation with the 51Cr-release assay. ADCC, HTCA, LAK, PBL
96  1985 Effects of platelet-derived growth factor and epidermal growth factor on antigen-induced proliferation of human T-cell lines. APC, EGF, PDGF
97  1985 Enhanced viral inhibition of lymphocyte mitogenesis in patients with advanced breast cancer. PHA
98  1985 Generation of human cytotoxic T lymphocytes against autologous solid tumors by autologous mixed lymphocyte tumor cell culture with T cell growth factor. CTL, MLTC
99  1985 Generation of T cell growth factor (TCGF)- dependent splenic lymphoid cell line with cell-mediated immunosuppressive reactivity against syngeneic murine tumor. ---
100  1985 HLA typing and karyotyping of limited numbers of lymphocytes is facilitated by in vitro expansion with TCGF. BM